ASX:OILHealth Care Equipment & ServicesHealth Care Equipment
Optiscan Imaging Ltd
$0.170
+$0.010 (+6.25%)
Day Range
$0.163 – $0.170
52 Week Range
$0.078 – $0.170
Volume
160.91K
Avg Volume (10D)
135.04K
Market Cap
$177.51M
Price Chart
Market Statistics
Open$0.163
Previous Close$0.160
Day High$0.170
Day Low$0.163
52 Week High$0.170
52 Week Low$0.078
Valuation
Market Cap177.51M
Shares Outstanding1.04B
Price to Book7.59
Trading Activity
Volume160.91K
Value Traded26.96K
Bid$0.165 × 2,072
Ask$0.180 × 50,000
Performance
1 Day0.00%
5 Day6.67%
13 Week48.84%
52 Week69.57%
YTD60.00%
Technical Indicators
RSI (14)68.00
50-Day SMA$0.140
200-Day SMA$0.111
Latest News
Biotechnology
Optiscan Imaging Advances Head and Neck Cancer Study Ahead of Schedule
Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions.
Biotechnology
Optiscan Imaging Launches First Clinical Device into US Veterinary Market
Optiscan debuts InSpecta as its first US commercial clinical imaging device after FDA CVM submission, unlocking US sales in a $15.9B market.
Biotechnology
Optiscan Submits FDA Dossier for Inspecta Imaging Device Targeting Lucrative US Veterinary Market
Optiscan submits FDA dossier for InSpecta veterinary imaging, unlocking US$11.9B market with real-time, non-invasive imaging for pets.
Biotechnology
Optiscan Imaging Launches Head and Neck Cancer Study Using Invue and InForm Digital Pathology Tools
Optiscan Imaging (ASX: OIL) has partnered with Australian Clinical Labs to launch the nation’s first-in-human head and neck cancer imaging study utilising the InVue and InForm digital pathology devices.